Combined Training (Strength and Endurance) and the Serum Levels of Myostatin and Hormone-sensitive Lipase in Overweight and Obese Men
Effect of Upper Body and Lower Body Combined Training (Strength and Endurance) on the Serum Levels of Myostatin and Hormone-sensitive Lipase in Overweight and Obese Men
1 other identifier
interventional
36
1 country
1
Brief Summary
This randomized controlled trial investigated the effects of upper body-based and lower body-based combined training on serum levels of myostatin (MSTN) and hormone-sensitive lipase (HSL) in overweight and obese men. Myostatin is a myokine involved in the regulation of skeletal muscle growth and adipose tissue metabolism, while HSL is a key enzyme involved in lipolysis and fat mobilization. Thirty-six overweight and obese men were assigned to either an upper body combined training group, a lower body combined training group, or a non-exercising control group. The intervention consisted of 10 weeks of combined resistance and aerobic training performed three times per week. Serum levels of MSTN and HSL were measured before and after the intervention to determine whether upper body-focused and lower body-focused combined training produce different effects on markers associated with muscle growth and lipid metabolism.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started May 2024
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 1, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 1, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
December 15, 2024
CompletedFirst Submitted
Initial submission to the registry
June 14, 2026
CompletedFirst Posted
Study publicly available on registry
June 18, 2026
CompletedJune 23, 2026
June 1, 2026
Same day
June 14, 2026
June 18, 2026
Conditions
Outcome Measures
Primary Outcomes (2)
Change in serum myostatin (MSTN) concentration
Serum myostatin concentration measured by enzyme-linked immunosorbent assay (ELISA). The outcome was assessed before the intervention and 48 hours after completion of the 10-week training program.
Baseline and 10 weeks
Change in serum hormone-sensitive lipase (HSL) concentration
Serum hormone-sensitive lipase concentration measured by enzyme-linked immunosorbent assay (ELISA). The outcome was assessed before the intervention and 48 hours after completion of the 10-week training program.
Baseline and 10 weeks
Study Arms (3)
Upper Body Combined Training
EXPERIMENTALParticipants completed a 10-week upper body-focused combined training program three times per week. Each session consisted of upper body resistance exercises followed by aerobic exercise performed on a hand ergometer. Resistance training included chest press, rowing machine, biceps curl, triceps extension, shoulder press, and abdominal exercises.
Lower Body Combined Training
EXPERIMENTALParticipants completed a 10-week lower body-focused combined training program three times per week. Each session consisted of lower body resistance exercises followed by aerobic exercise performed on a leg ergometer. Resistance training included leg press, leg extension, leg flexion, leg abduction, leg adduction, and calf raise exercises.
Control
NO INTERVENTIONParticipants in the control group did not participate in the exercise intervention and were instructed to maintain their usual daily activities throughout the 10-week study period.
Interventions
Participants completed a 10-week upper body-focused combined training program performed three times per week. Each session included six upper body resistance exercises (chest press, rowing machine, biceps curl, triceps extension, shoulder press, and abdominal machine exercises) followed by aerobic exercise on a hand ergometer. Resistance training was performed for 3 sets during the first 5 weeks and 4 sets during weeks 6-10, with 8-12 repetitions per set. Aerobic exercise began at 20 minutes and increased by 1 minute each week, reaching 29 minutes in the final week. Exercise intensity was maintained at approximately 57-66% of maximum heart rate during aerobic training.
Participants completed a 10-week lower body-focused combined training program performed three times per week. Each session included six lower body resistance exercises (leg press, leg extension, leg flexion, leg abduction, leg adduction, and calf raise exercises) followed by aerobic exercise on a leg ergometer. Resistance training was performed for 3 sets during the first 5 weeks and 4 sets during weeks 6-10, with 8-12 repetitions per set. Aerobic exercise began at 20 minutes and increased by 1 minute each week, reaching 29 minutes in the final week. Exercise intensity was maintained at approximately 57-66% of maximum heart rate during aerobic training.
Eligibility Criteria
You may qualify if:
- Male participants aged 20 to 45 years.
- Body mass index (BMI) ≥25 kg/m².
- Overweight or obese status.
- No participation in regular resistance or aerobic exercise during the previous 6 months.
- Willingness to participate and provide written informed consent.
You may not qualify if:
- Presence of metabolic diseases, including diabetes mellitus.
- Presence of cardiovascular or respiratory diseases.
- Musculoskeletal or joint injuries that could interfere with exercise participation.
- Use of anti-obesity medications.
- Use of anabolic steroids, sports supplements, or fat-burning supplements.
- Regular alcohol consumption or tobacco use.
- Absence from more than two training sessions during the intervention period.
- Withdrawal of consent or unwillingness to continue participation.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Arya Habibilead
Study Sites (1)
Faculty of Sports and Health Sciences of the University of Tehran
Tehran, Tehran Province, Iran
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Masking Details
- No masking was used in this study. Participants, investigators, and study personnel were aware of group assignments due to the nature of the exercise interventions.
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
June 14, 2026
First Posted
June 18, 2026
Study Start
May 1, 2024
Primary Completion
May 1, 2024
Study Completion
December 15, 2024
Last Updated
June 23, 2026
Record last verified: 2026-06
Data Sharing
- IPD Sharing
- Will not share
Individual participant data (IPD) will not be made publicly available. The study was not originally designed with a formal data-sharing plan, and participant-level data contain information that could potentially compromise participant confidentiality.